| Health / Medical Topics |
MoAb HuM195
A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. MoAb HuM195 is a type of monoclonal antibody. Also called lintuzumab and monoclonal antibody HuM195. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of cancer. It binds to a molecule called GD2, which is found in greater than…
A monoclonal antibody directed against the neurohormone bombesin that is conjugated to isothiocyanobenzyl diethylenetriaminepentaacetic acid (ITC-D), a bifunctional chelating agent that allows…
A monoclonal antibody directed against the neurohormone bombesin that is conjugated to diethylenetriaminepenta-acetic acid (DPTA), a bifunctional chelating agent that allows the…
A monoclonal antibody B3, recognizing the tumor-associated Lewis Y antigen, is conjugated to a backbone-substituted derivative of DTPA, 2-(p-isothiocyanatobenzyl)-cyclohexyl-diethylenetriaminepentaacetic acid (CHX-A…
Molybdenum ion requiring six electrons to return to its elemental state.
Molybdenum ion requiring four electrons to return to its elemental state.
